99 patients suffering from therapy-resistant depression, meaning they did not improve when previously taking anti-depressant drugs or electroconvulsive therapy, were given 5-HTP at an average of 200 mg per day combined with the peripheral decarboxylase inhibitor, carbidopa. Complete recovery was…
In 1991, 5-HTP was compared to the SSRI fluvoxamine (Luvox) for effectiveness against depression. Fluvoxamine is comparable to other SSRIs, such as Prozac, Zoloft and Paxil. In the study, 36 patients received either 300 mg daily of 5-HTP or 150…
The effectiveness of 5-HTP as an antidepressant drug was studied with 59 patients with depressive symptoms using the Rating Scale for Depression. In this double-blind clinical study of 5-HTP treatment of depression, a daily dose of 150 - 300 mg…
Previous observations have shown that oral administration of 5-HTP without dietary prescriptions causes decreased appetite, decreased food intake, and weight loss in obese subjects. To confirm these data over a longer period of observation and to verify whether adherence to…
